Skip to main content
logo
Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia flag Australia · Delayed Price · Currency is AUD
2.890
+0.100 (3.58%)
At close: Feb 5, 2026

Clarity Pharmaceuticals Revenue

In the fiscal year ending June 30, 2025, Clarity Pharmaceuticals had annual revenue of 9.46M AUD, down -17.76%. Clarity Pharmaceuticals had revenue of 4.77M in the half year ending June 30, 2025, with 17.37% growth.

Revenue
9.46M
Revenue Growth
-17.76%
P/S Ratio
113.62
Revenue / Employee
137.14K
Employees
69
Market Cap
1.08B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20259.46M-2.04M-17.76%
Jun 30, 202411.51M1.71M17.41%
Jun 30, 20239.80M3.34M51.74%
Jun 30, 20226.46M3.26M102.06%
Jun 30, 20213.20M407.65K14.62%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Telix Pharmaceuticals1.01B
Neuren Pharmaceuticals218.86M
Clinuvel Pharmaceuticals95.02M
Mesoblast26.23M
PYC Therapeutics23.49M
Orthocell7.55M
Racura Oncology6.04M
Botanix Pharmaceuticals5.79M
Revenue Rankings

Clarity Pharmaceuticals News

More News